Cambridge Cognition
Cambridge Cognition is a leading brain health software group at the forefront of digital health innovation, dedicated to advancing brain health research and treatment through cutting-edge technology solutions.
Built on a foundation of rich, curated data and deep technical expertise, Cambridge Cognition is establishing itself as a strong global brand with scalable technology designed to meet the rising worldwide demand for brain health diagnosis and treatment solutions. Our commitment to innovation drives us to create lasting shareholder value through organic sales growth, strategic partnerships, joint ventures, and strategic spinouts.
Cambridge Cognition is a brain health software group specialising in digital health products that advance brain health research and treatment.
Built on rich, curated data and deep technical expertise we are building a strong global brand with scalable technology that will support the rising world demand for diagnosing and treating brain health. The Company creates shareholder value through organic sales growth, strategic partnerships, joint ventures, and spinouts. The Company has identified four market sectors:
Clinical Studies for new pharmaceuticals;
Academic Research for scientists to understand CNS disorders;
Healthcare to provide physicians with cognitive assessments to allow them to diagnose and treat patients; and,
Consumer Health & Wellness to provide individuals access to accurate, reliable, and meaningful data to assess their cognitive health.
For further information, visit: www.cambridgecognition.com
Cambridge Cognition is a really exciting and innovative company to work for. The people here are great, everyone is so friendly and supportive of each other. It is a very positive working environment, we all work hard and all believe in what we're doing. It's great to work for a company that is making a difference in shaping the future of health.
Products and services
Data Management Services
Cambridge Cognition's AQUA (Automated Quality Assurance) platform addresses critical data quality challenges in CNS clinical trials, delivering up to 60% cost savings compared to traditional quality assurance providers while maintaining superior data integrity.
Cambridge Cognition understands that conventional rater training can often be cumbersome and inefficient. To address this, we have developed an advanced rater qualification and management program that ensures raters are well-prepared to conduct cognitive assessments to the highest standards, all while simplifying the training process.
Core Problem Addressed
- High CNS trial failure rates: 85% of Phase 2 and 3 trials fail
- Manual QA limitations: Slow, expensive, and non-scalable processes
- Scale administration errors: Even minor mistakes can negatively impact trial outcomes
- Training complexity: Standard scales require extensive training to administer and score properly
Electronic Questionnaires and Scales
Digital bespoke questionnaires and universally recognised clinical scales
Our eCOA tools helps you to collect valid data within tight deadlines, with the support of our expert teams who configure your electronic questionnaires and scales to your specification, support study set up, data management and handling clinical scales licenses, enabling you to deliver your study faster.
Digital Assessments
CANTAB® assessments and voice biomarkers provide scientifically validated, highly sensitive, precise and objective measures of cognitive function, correlated to neural networks.
Keep your participants engaged with our simple and user-friendly tasks, whether in-clinic or at home. Our neuroscientists and consultants work with you to build a battery of CANTAB cognitive assessments that will best enable you to reach your study objectives.
Using voice biomarkers brings an additional layer of understanding to cognitive assessments by accounting for both content (what is said) and acoustic properties (how it is said). This creates a fuller understanding of patient functioning at both an individual and group level.
